Johnson & Johnson Faces UK Lawsuit Over Alleged Asbestos in Talcum Powder
Over 3,000 UK individuals are suing Johnson & Johnson, alleging its talcum powder contained carcinogenic asbestos, causing cancer. The company allegedly knew for decades, removing the product globally in 2023.
Overview
Thousands of people in the United Kingdom are jointly suing Johnson & Johnson, claiming its baby powder was contaminated with carcinogenic asbestos.
Over 3,000 plaintiffs allege that asbestos in Johnson & Johnson's talcum powder caused them to develop cancer and other serious diseases.
The lawsuit contends Johnson & Johnson allegedly knew about the carcinogenic fibers in their talc products for over fifty years.
Johnson & Johnson globally removed its talc-based baby powder from shelves in 2023, following numerous allegations and legal actions.
Legal inquiries are now directed to Kenvue, Johnson & Johnson's former consumer health business, regarding liability for the alleged harm.
Analysis
Center-leaning sources cover this story neutrally, presenting the serious allegations against Johnson & Johnson regarding asbestos in talcum powder and the company's strong denials. They provide historical context of legal battles and regulatory actions, attributing all claims and counter-claims to their respective sources, thus avoiding editorial bias in their reporting.
FAQ
The plaintiffs allege that the asbestos-contaminated talcum powder caused ovarian cancer and mesothelioma[1].
The plaintiffs refer to internal research, mine reports, and existing scientific literature, asserting that these sources would have informed Johnson & Johnson about asbestos contamination in their talc[1].
Kenvue, previously part of Johnson & Johnson, states that the talc used in their baby powder complied with regulations, did not contain asbestos, and does not cause cancer[1].
Johnson & Johnson globally removed its talc-based baby powder from shelves in 2023 following numerous allegations and legal actions[1].
The lawsuit seeks to hold both Johnson & Johnson and its current and former subsidiaries, including Kenvue UK, liable for the alleged harm[1].